Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro
- 22 July 1993
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 364 (6435) , 352-355
- https://doi.org/10.1038/364352a0
Abstract
THE Ras proteins are key regulators of the growth of eukaryotic cells, but their direct target enzymes, or 'effectors', are unknown1. The protein encoded by the c-raf-1 proto-oncogene is thought to function downstream of p21ras because disruption of Raf blocks signalling by Ras in a number of systems2–5. Here we report that the amino-terminal cysteine-rich regulatory region of p74c-raf-1 expressed as a glutathione-S-transferase (GST) fusion protein binds directly to Ras with relatively high affinity (50 nM). The binding is strictly dependent on the Ras protein being in the active GTP-bound conformation rather than the inactive GDP-bound state. Raf–GST interacts with wild-type and oncogenic Ras (Val 12) but fails to interact with a biologically inert effector mutant of Ras (Ala 38) and a dominant negative mutant (Asn 17). A peptide based on the effector region of Ras inhibits the interaction. Raf–GST acts as a potent competitive inhibitor of the GTPase-activating proteins p120GAPand neurofibromin. In addition, Raf itself displays weak GTPase-stimulating activity towards Ras. It is therefore likely that Raf is a direct effector of Ras.Keywords
This publication has 18 references indexed in Scilit:
- C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiationNature, 1993
- The mitogen-activated protein kinase activatorCurrent Opinion in Cell Biology, 1992
- Raf functions downstream of Rasl in the Sevenless signal transduction pathwayNature, 1992
- The target sets the tempoNature, 1992
- Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase.Genes & Development, 1992
- Regulatory mechanisms for ras proteinsBioEssays, 1992
- How does p21ras transform cells?Trends in Genetics, 1991
- Preferential inhibition of the oncogenic form of RasH by mutations in the GAP binding/“effector” domainCell, 1991
- Stimulation of p21ras upon T-cell activationNature, 1990
- Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cellsNature, 1985